Clinical Trial Update: Use of a Dual-agent Local Analgesic (Bupivacaine-meloxicam) for Abdominal Incisions in Patients Undergoing Retropubic Mid-urethral Sling Surgery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a dual-agent local analgesic (bupivacaine-meloxicam) for abdominal incisions in women undergoing retropubic mid-urethral sling…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Urinary Incontinence

Drugs mentioned

• Bupivacaine-meloxicam dual-agent local analgesic (bupivacaine and meloxicam)

Snippet

Sponsor: TriHealth Inc. | Conditions: Stress Urinary Incontinence, Surgical Incision | Phase 3 | Status: COMPLETED